Polygiene Group (Q3 Review): Recovery in Sight - Redeye

Redeye returns with a more optimistic outlook following Polygiene’s Q3 2025 report, which presented mixed figures but confirmed our expectations of a recovery in Q4 ’25. We make smaller positive estimate adjustments while our valuation range remains intact. We argue that the macro effects are transitory, staying positive to the long-term case which trades at an attractive valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/1132271/polygiene-group-q3-review-recovery-in-sight?utm_source=finwire&utm_medium=RSS